These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17453607)

  • 41. The dopamine uptake inhibitor 3 alpha-[bis(4'-fluorophenyl)metoxy]-tropane reduces cocaine-induced early-gene expression, locomotor activity, and conditioned reward.
    Velázquez-Sánchez C; Ferragud A; Hernández-Rabaza V; Nácher A; Merino V; Cardá M; Murga J; Canales JJ
    Neuropsychopharmacology; 2009 Nov; 34(12):2497-507. PubMed ID: 19606084
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasticity of addiction: a mesolimbic dopamine short-circuit?
    Niehaus JL; Cruz-Bermudez ND; Kauer JA
    Am J Addict; 2009; 18(4):259-71. PubMed ID: 19444729
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cocaine exposure enhances excitatory synaptic drive to cholinergic neurons in the laterodorsal tegmental nucleus.
    Kurosawa R; Taoka N; Shinohara F; Minami M; Kaneda K
    Eur J Neurosci; 2013 Oct; 38(7):3027-35. PubMed ID: 23822660
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Extinction-induced neuroplasticity attenuates stress-induced cocaine seeking: a state-dependent learning hypothesis.
    Self DW; Choi KH
    Stress; 2004 Sep; 7(3):145-55. PubMed ID: 15764012
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The neural rejuvenation hypothesis of cocaine addiction.
    Dong Y; Nestler EJ
    Trends Pharmacol Sci; 2014 Aug; 35(8):374-83. PubMed ID: 24958329
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biphasic alterations in serotonin-1B (5-HT1B) receptor function during abstinence from extended cocaine self-administration.
    O'Dell LE; Manzardo AM; Polis I; Stouffer DG; Parsons LH
    J Neurochem; 2006 Dec; 99(5):1363-76. PubMed ID: 17074068
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The biological mechanisms underlying alcohol dependence].
    Alling C
    Lakartidningen; 1999 Jul; 96(28-29):3248-52. PubMed ID: 10434508
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurobiology. Total recall-the memory of addiction.
    Nestler EJ
    Science; 2001 Jun; 292(5525):2266-7. PubMed ID: 11423644
    [No Abstract]   [Full Text] [Related]  

  • 49. Minding the brain: the role of pharmacotherapy in substance-use disorder treatment.
    Elias D; Kleber HD
    Dialogues Clin Neurosci; 2017 Sep; 19(3):289-297. PubMed ID: 29302226
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synaptic plasticity and drug addiction.
    Jones S; Bonci A
    Curr Opin Pharmacol; 2005 Feb; 5(1):20-5. PubMed ID: 15661621
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Perspectives on current directions in the neurobiology of addiction disorders relevant to genetic risk factors.
    Hurd YL
    CNS Spectr; 2006 Nov; 11(11):855-62. PubMed ID: 17075557
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Astrocytes in cocaine addiction and beyond.
    Wang J; Holt LM; Huang HH; Sesack SR; Nestler EJ; Dong Y
    Mol Psychiatry; 2022 Jan; 27(1):652-668. PubMed ID: 33837268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Accessories to addiction: G protein regulators play a key role in cocaine seeking and neuroplasticity.
    Kelley AE; Schiltz CA
    Neuron; 2004 Apr; 42(2):181-3. PubMed ID: 15091332
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New treatments for cocaine dependence: a focused review.
    Karila L; Gorelick D; Weinstein A; Noble F; Benyamina A; Coscas S; Blecha L; Lowenstein W; Martinot JL; Reynaud M; Lépine JP
    Int J Neuropsychopharmacol; 2008 May; 11(3):425-38. PubMed ID: 17927843
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expanding treatment of tobacco dependence.
    Harris DS; Anthenelli RM
    Curr Psychiatry Rep; 2005 Oct; 7(5):344-51. PubMed ID: 16216152
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.
    Haile CN; Mahoney JJ; Newton TF; De La Garza R
    Pharmacol Ther; 2012 May; 134(2):260-77. PubMed ID: 22327234
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Striatal signal transduction and drug addiction.
    Philibin SD; Hernandez A; Self DW; Bibb JA
    Front Neuroanat; 2011; 5():60. PubMed ID: 21960960
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Altered glutamatergic and GABAergic mechanisms in the cingulate cortex of the schizophrenic brain.
    Benes FM
    Arch Gen Psychiatry; 1995 Dec; 52(12):1015-8; discussion 1019-24. PubMed ID: 7492253
    [No Abstract]   [Full Text] [Related]  

  • 59. Proteome-Informed Machine Learning Studies of Cocaine Addiction.
    Gao K; Chen D; Robison AJ; Wei GW
    J Phys Chem Lett; 2021 Nov; 12(45):11122-11134. PubMed ID: 34752088
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Emerging drugs for the treatment of cocaine use disorder: a review of neurobiological targets and pharmacotherapy.
    Shorter D; Domingo CB; Kosten TR
    Expert Opin Emerg Drugs; 2015 Mar; 20(1):15-29. PubMed ID: 25425416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.